Toward Precision Andrology: Advancing Semen Testing to Resolve the Enigma of 'Idiopathic' Male Infertility.
Abstract
Despite decades of advancements, conventional semen analysis continues to leave nearly 40% of infertile men labeled as 'idiopathic', denoting abnormal semen parameters in the absence of remarkable abnormalities in genital examination. The emerging discipline of precision andrology attempts to bridge this diagnostic gap by integrating advanced semen examinations that cross-examine molecular, oxidative, and structural extents of sperm function. This review critically synthesizes evidence from recent experimental and clinical studies outlining how oxidative stress assays, sperm DNA fragmentation testing, chromatin packaging evaluation, epigenetic alteration assessment, and, proteomic and metabolomic profiling, collectively redefine male infertility diagnostics. These approaches expose mechanistic defects, redox imbalance, genomic and epigenomic instability, and subtle inflammatory or immune perturbations that remain invisible to traditional microscopy. We discuss their clinical translation, standardization challenges, and interpretive drawbacks while proposing a tiered framework that couples basic and advanced assessments for stepwise phenotyping. By reclassifying 'idiopathic' infertility into detectable categories such as redox-deficient, genomic-unstable, or immune-inflammatory subtypes, such precision diagnostics promise individualized interventions, optimized assisted reproduction strategies, and improved prognostic accuracy. The review underscores the urgent need for consistent reference ranges, validated cut-offs, and phenotype-based clinical trials to translate these research-grade tools into routine andrology practice, ultimately transforming the notion of 'idiopathic' male infertility from a diagnosis of exclusion to one of measurable functional insight.